About
EnCompass Technologies
Our Vision
To eliminate brain injury, including stroke, due to embolic debris during cardiac procedures.
Our Mission
To benefit patients by advancing effective, efficient, and safe embolic filtration across the spectrum of cardiac procedures.
Our Leadership
Executive Team
George Wallace
Founder and CEO
Over 40 years medical device experience. Has built, financed, and exited multiple cardio- & neurovascular companies.
Mike Jones
Founder and VP of R&D
35 years medical device experience in product development & manufacturing across 5+ cardio- & neurovascular companies. 106 medical device patents.
Carl Swindle
Senior Direction of R&D and Operations
35 years medical device experience in R&D, business development, operations, clinical and marketing. Heart disease and neurology expertise.
Kathleen Calderon
Senior Director of Clinical
Over 20 years medical device experience in clinical trial management at small and large companies.
Lauren Baker, ME, PhD
Regulatory & Clinical
Over 30 years medical device experience in regulatory & clinical. CEO of Insight Medical Consulting.
Gerard VonHoffmann
Design & IP
35 years medical device experience as patent attorney at Knobbe.
Contractors
Insight Medical Consulting (CRO); Avania US/AUS (CRO); Dr. May Nour, NeuroMerit (Core Lab); Oculus Imaging (MRI Core Lab)
Board of Directors
George Wallace
CEO & Director
Bill Starling
Director
Chris Martin
Director
Steve Gex
Director
Avi Roop
Director
Medical Advisors
Tamim Nazif, MD
Isaac George, MD
Cardiac Surgeon
NY Presbyterian/Columbia Univ, NYC
Steve Yakubov, MD
Interventional Cardiologist
Riverside Methodist Hosp, Columbus
Bill O’Neill, MD
Interventional Cardiologist
Henry Ford Hospital, Detroit
Jim Hermiller, MD
Interventional Cardiologist
St. Vincent’s Hospital, Indianapolis
Ulrich Schaefer, MD
Interventional Cardiologist
Hospital Bonn, Germany
Dee Dee Wang, MD
Cardiac Imaging
Henry Ford Hospital, Detroit
May Nour, MD, PhD
Vascular & Interventional Neurologist
UCLA
Newsroom
Press Release
May 23, 2023
World's First Use of EnCompass Medical Device to Protect Against Brain Injury Achieved at the Israeli-Georgian Medical Research Clinic, Tbilisi, Georgia
Abstract
July 30, 2023
E-088 A novel neuroprotection device, EnCompass F2 for improved stroke prevention in transcatheter aortic valve replacement: an in vitro study
Press Release
September 27, 2023
